Medicare Copays For New Alzheimer’s Drug Could Reach $11,500 Annually: NPR

Federal regulators approved the drug Aduhelm for Alzheimer’s patients. Biogen via AP toggle caption Biogen via AP Federal regulators approved the drug Aduhelm for Alzheimer’s patients. Biogen via AP WASHINGTON — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 … Read more